Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | CNR2 | P34972 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.58 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8035990 | 1.00 | POLB (0.63) | POLBCNR2MEN1KMT2ACYP1A2 | |
| SCHEMBL2177216 | 1.00 | POLB (0.63) | POLBCNR2MEN1KMT2ACYP1A2 | |
| SCHEMBL15743800 | 0.87 | POLB (0.61) | POLBCNR2MEN1KMT2ACYP1A2 | |
| SCHEMBL27343284 | 0.87 | POLB (0.61) | POLBCNR2MEN1KMT2ACYP1A2 | |
| SCHEMBL31416461 | 0.86 | POLB (0.52) | POLBCNR2MEN1KMT2ACYP1A2 | |
| SCHEMBL6136486 | 0.86 | HPGD (0.58) | CNR2MEN1KMT2AALDH1A1PSMB8 | |
| SCHEMBL6136490 | 0.86 | HPGD (0.58) | CNR2MEN1KMT2AALDH1A1PSMB8 | |
| SCHEMBL5842514 | 0.86 | POLB (0.59) | POLBCNR2MEN1KMT2ACYP1A2 | |
| SCHEMBL9783328 | 0.85 | POLB (0.67) | POLBCNR2MEN1KMT2ACYP1A2 | |
| SCHEMBL7674546 | 0.85 | POLB (0.67) | POLBCNR2MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-03 | — | — | US | claimed |
| US-20240290431-A1 | BIOMARKER AND DIAGNOSIS SYSTEM FOR COLORECTAL CANCER DETECTION | HANGZHOU CALIBRA DIAGNOSTICS CO LTD (CN) | 2024-08-29 | — | — | US | claimed |
| US-20230402131-A1 | BIOMARKER AND DIAGNOSIS SYSTEM FOR COLORECTAL CANCER DETECTION | HANGZHOU CALIBRA DIAGNOSTICS CO., LTD. (CN) | 2023-12-14 | — | — | US | claimed |
| US-20230400438-A1 | METHODS AND CONSUMER PRODUCTS FOR DETECTING A METABOLITE | KIMBERLY-CLARK WORLDWIDE, INC. | 2023-12-14 | — | — | US | claimed |
| CN-115436633-A | Biomarker for colorectal cancer detection and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-115440375-A | Colorectal cancer prediction system and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-114758719-B | Colorectal cancer prediction system and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-114755422-B | Biomarker for colorectal cancer detection and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-114758719-A | Colorectal cancer prediction system and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-114755422-A | Biomarker for colorectal cancer detection and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-07-15 | — | — | CN | claimed |
| EP-1047391-A4 | ALPHA-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2005-01-19 | — | — | EP | claimed |
| US-20030191119-A1 | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | WU JING (US) | 2003-10-09 | — | — | US | claimed |
| US-20020137743-A1 | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | WU JING (US) | 2002-09-26 | — | — | US | claimed |
| US-6238655-B1 | USEFUL IN THE FORMULATION OF DEODORANTS, ANTIPERSPIRANTS, BODY SPRAYS, AND OTHER SKIN TREATMENT COMPOSITIONS. | THE GILLETTE COMPANY | 2001-05-29 | — | — | US | claimed |
| EP-1047391-A1 | ALPHA-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 2000-11-02 | — | — | EP | claimed |
| EP-0951464-A1 | N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS | Elan Pharmaceuticals, Inc. (US) | 1999-10-27 | — | — | EP | claimed |
| WO-1999030679-A1 | α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 1999-06-24 | — | — | WO | claimed |
| WO-1998046599-A1 | NOVEL CARBOXAMIDES AS PLATELET AGGREGATION INHIBITORS | J. URIACH & CIA. S.A. (ES) | 1998-10-22 | — | — | WO | claimed |
| WO-1998022430-A9 | N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING b-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS | — | 1998-08-20 | — | — | WO | claimed |
| WO-1998022430-A1 | N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING b-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS | ELAN PHARMACEUTICALS, INC. (US) | 1998-05-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137743-A1 | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | APP, BACE1, IAPP | POLB 3668/4885CNR2 1983/4885MEN1 2296/4885 |
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | SLC6A6, SLC7A11, CTH | POLB 2035/4885CNR2 2980/4885MEN1 4783/4885 |
| US-20030191119-A1 | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | APP, BACE1, IAPP | POLB 3668/4885CNR2 1983/4885MEN1 2296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.